Reditux is the trade name of a non-comparable biologic (NCB) version of Rituximab. It Is mainly used in the treatment of certain lymphomas, leukaemias and rheumatoid arthritis. It was first launched on April 30, 2007 in Hyderabad, India.
Safe to use
Precise pH value
Long shelf life
904, 9th floor, Sunshine Tower, Senapati Bapat Marg, Dadar West, Mumbai, Maharashtra, 400012, India